Supporting this model, pharmacological inhibition of lysosomal acidification with bafilomycin A1 increases EV release and promotes the secretion and transmission of alpha-synuclein—a key protein in PD pathogenesis—via exosomes [37,38]. This evidence concerns the gene SNCA and Parkinson disease.